plasma prothrombin time 血浆凝血酶原时间
plasma prothrombin activity 血浆凝血酶原活动度
plasma prothrombin fragment 血浆凝血酶原片段
plasma prothrombin time pt 凝血酶原时间
plasma prothrombin time detection 血浆凝血酶原时间测定
plasma prothrombin conversion factor 血浆凝血酶原转化因子
plasma prothrombin conversion accelerator 血浆凝血酶原转化加速剂
plasma abnormal prothrombin 血浆异常凝血酶原
Prothrombin G20210A mutation can lead to plasma prothrombin level increase.
凝血酶原基因g20210a突变,可导致血浆凝血酶原水平升高。
There was no significant difference in platelet count, plasma prothrombin time and plasma viscosity between treatment group and control group ( P > 0.05) .
治疗组血小板计数、凝血酶原时间及血浆黏度变化与对照组相似(P>0.05)。
Plasma prothrombin time (PT), activate part plasma prothrombin time (APTT), prothrombin time (TT) , fibrinogen (FIB) the level of fasting blood glucose (GLU) are tested separately.
分别测定血浆凝血酶原时间(PT)、活化部分凝血酶原时间(APTT)、凝血酶时间(TT),纤维蛋白原(FIB)、血清空腹血糖(GLU)水平。
应用推荐